Market News AIOpen the app

60 Degrees Pharmaceuticals lost $0.75 per share last quarter, missing the expected loss of $0.73, with sales at $233,235.

ResultsRead the original at moomoo.com
Bad for SXTP

60 Degrees Pharmaceuticals reported a $0.75 per-share loss and $233,235 in sales, missing both estimates. The story's claimed 71.8% rise from a $2.66 prior loss conflicts with those figures, so the two misses drive the unfavorable read.

SXTP · 60 Degrees Pharmaceuticals

AI read · Bad for SXTP

The AI's read

Missing both estimates leaves the report unfavorable. The prior-period comparison is contradictory: it calls a $0.75-per-share loss a 71.8% increase from $2.66 per share, though $0.75 is smaller.

Get alerts for SXTP

Follow 60 Degrees Pharmaceuticals (SXTP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SXTP
Free on the App Store and Google Play, or on the web.